Zoledronic Acid
Product Images NDC 60505-6110

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Zoledronic Acid (NDC 60505-6110). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Apotex Corp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Zoledronicacid01 (Zoledronicacid01)

Chemical structure diagram of Zoledronic Acid showing its molecular composition with imidazole ring and phosphate groups, along with associated water molecule.*

FDA Label Image

Zoledronicacid02 (Zoledronicacid02)

A bar chart titled 'Proportion of Complete Responders by Day 10 in Pooled HCM Studies' comparing the percentage of complete responders between Zoledronic acid injection 4 mg (n=86) and Pamidronate 90 mg (n=99). Zoledronic acid shows a higher response rate near 80%, while Pamidronate is around 65%, with a significance level indicated as P=0.002.*

FDA Label Image

Zoledronicacid03 (Zoledronicacid03)

Label for Zoledronic Acid Injection 4 mg/5 mL (0.8 mg/mL) concentrate for intravenous infusion in a single 5 mL vial. The label includes storage instructions, manufacturer Apotex Corp, lot and expiration date fields, and barcode information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.